ALBUQUERQUE, N.M. (AP) — University of New Mexico researchers say the legal availability of medical marijuana has the potential to reduce opioid use among chronic pain patients.
The work of associate psychology professor Jacob Miguel Vigil and assistant economics professor Sarah See Stith was recently published in the journal PLOS ONE.
The results indicate a strong correlation between enrollment in New Mexico’s medical marijuana program and cessation or reduction of opioid use.
Vigil says informal surveys showed a significant proportion of patients substituted their opioid prescriptions with cannabis.
Most Read Stories
- Swedish Health’s ambitious Seattle plans involved a developer with a stake in their success VIEW
- Prison escape of Darren Berg, Washington’s ‘Mini Madoff,' is like ‘Shawshank Redemption,' official says
- Video surfaces of Seahawks' top draft pick Malik McDowell's arrest, and it is very NSFW
- Seattle police recommend charging ex-City Council candidate for false reporting in voucher program | Times Watchdog
- Washington state drivers 5th worst in nation — and trending in the wrong direction, new study says
The study tracked 37 habitual opioid using, chronic pain patients who enrolled in the state medical marijuana program between 2010 and 2015, compared to 29 patients with similar health conditions who didn’t enroll.
As of October, more than 44,000 people were enrolled in the state program.